Flatiron Health’s Post

At Mythic, we believe that taking on #cancer requires more than just cutting-edge technology and innovative science. It takes grit and dedication — qualities that our team strives to exemplify every single day.     From relentless research to breakthrough discoveries, we are driven by a shared goal: to develop a new dimension of #ADCs to transform cancer treatment and expand the number of patients who might benefit from targeted therapies.    Learn how we are pushing boundaries and making strides in the fight against cancer: https://bit.ly/4bSATXW     #MythicProud 

RESEARCH 🟰 PROGRESS❗ This #NationalCancerResearchMonth, we’re united in progress toward a world without #BloodCancer. 💪 Did you know: 🔬 With a current investment of $248.3 million in blood cancer research, we're driving progress toward better treatments and improved outcomes. 🔬 LLS has played a crucial role in advancing 70% of blood cancer drug approvals in the last two decades. 🔬 We're supporting 289 blood cancer research projects led by innovative scientists worldwide. And your support helps move us forward! Dive in to learn more about our research commitment 👉 https://bit.ly/3QIcDQo

Today marks #WorldLungCancerDay, a time to raise awareness and support those affected by this disease. 🫁 At MiBA, we're committed to driving progress in lung cancer research and care. Let's work together to turn our insights into your actions. Whether you're a researcher, clinician, or industry partner, explore how our comprehensive dataset can support your efforts in the fight against lung cancer: https://bit.ly/3XQr754 #DataDrivenOncology #CancerResearch

Stephen Liu and Isabel Preeshagul will discuss the latest scientific readouts from International Association for the Study of Lung Cancer's Targeted Therapies meeting. I look forward to learning from this dynamic duo every year! #lungcancer #research

2023 has been stand out year for us at Cerca Biotech. We doubled our team, added a major partner in Sysmex Europe, and we were present at all the major #BreastCancer congresses. Find out more about what else we have done this year to move breast cancer diagnostics forwards, in our latest update: link in the comments. #Biotech #HealthInnovation #CancerDiagnostics

In this AJMC - The American Journal of Managed Care interview, Mark A. Socinski, MD, executive director at AdventHealth Cancer Institute, discusses the importance of lung cancer screening in eligible patients, including the need for primary care providers to ensure screening is being implemented. Watch here!

It’s Time to Accelerate Cancer Screening! 🌟 First-hand experiences are essential for understanding the state of #CancerScreening policies across Europe. Help us collect and identify best practices and lessons learned from across countries and across cancer types. 🔍 If you are intrested and involved in cancer screening, please take our survey 👉 https://buff.ly/48UOYT3

2023 Highlight: Transforming Lung Cancer Through Research This year, LUNGevity committed approximately $5.5 million for 13 new multi-year research grants for projects centered on early detection, as well as studies to support veterans, improve health equity, and develop new treatment options. We wish to thank our partners—the EGFR Resisters and the American Society for Radiation Oncology—for their ongoing commitment as we invest jointly in meaningful lung cancer research. Learn more about lung cancer research by visiting https://lnkd.in/dg23mrUZ #transforminglungcancer #lungevityresearch #lungcancerresearch

🗓️August is World Lung Cancer Day 🫁 Through the Time to Accelerate: for Cancer Screening campaign ECO is uniting medical societies and patient groups to implement and update national screening strategies across the EU. Read more 🔗 https://lnkd.in/dUAGi_pS Together, we can make a difference! #EUCancerPlan

In a trailblazing move to improve cancer care, a panel discussion titled ‘Cancer Moonshots Across the Continuum’ was recently held, moderated by #JPMorgan. The panel focused on strategies to cut the cost of cancer care and the mortality rate in half. This article delves into the key takeaways from this impactful discussion and the consequent implications for the future of cancer care.